Skip to content

Clinical trials

Completed Phase 4 Insulin Resistance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 4 Status: Completed Clear all

204 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20024
200311
200413
200518
200611
200714
200812
200912
20109
201116
201211
20136
201411
20159
20169
20173
20187
20196
20201
20214
20222
20235
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed204

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gachon University Gil Medical Center11
Eli Lilly and Company4
Tanabe Pharma Corporation4
Tottori University Hospital4
AstraZeneca3
German Diabetes Center3
Mannkind Corporation3
Massachusetts General Hospital3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Stanford University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance204
Diabetes Mellitus, Type 256
Diabetes Mellitus54
Obesity22
Metabolic Syndrome18
Diabetes Mellitus, Type 113
Hypertension13
Hyperglycemia10
Prediabetic State10
Glucose Intolerance9

Trials

Showing 1 to 25 of 204. Each trial links to its page on Pharma Observatory.

104 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.